Roche announces results from Evrysdi (risdiplam) study in infants with Type 1 spinal muscular atrophy (SMA) published in New England Journal of Medicine

FIREFISH Part 1 data show treatment with Evrysdi at 12 months helped 90% of these infants survive without permanent ventilation and 33% sit without support, a key motor milestone not normally seen in the natural course of the disease The FDA approved Evrysdi in August 2020 as the first and only at home SMA treatment... Read more

JEOL Introduces New Time-of-Flight Mass Spectrometer JMS-T2000GC AccuTOF GC-Alpha

February 23, 2021, Peabody, Mass. – JEOL builds upon its legacy of successful AccuTOFTM GC series gas chomatograph – time-of-flight mass spectrometers with the release of the JMS-T2000GC “AccuTOF™ GC-Alpha”. This product is a GC-MS that represents significant improvement in performance and functionality using two newly developed key technologies. The basic hardware performance has been greatly improved and... Read more

JEOL Introduces New Time-of-Flight Mass Spectrometer JMS-T2000GC AccuTOF™ GC-Alpha

February 17, 2021, Peabody, Mass. – JEOL builds upon its legacy of successful AccuTOF™ GC series gas chromatograph – time-of-flight mass spectrometers with the release of the JMS-T2000GC “AccuTOF™ GC-Alpha”. This product is a GC-MS that represents significant improvement in performance and functionality using two newly developed key technologies. The basic hardware performance has been greatly improved... Read more

Release of the Novel Coronavirus Detection Kit for Wipe Tests Allows quick and easy detection of the novel coronavirus on touch screens, doorknobs, etc. for efficient health and safety management

February 22, 2021 The Novel Coronavirus Detection Kit for Wipe Tests Shimadzu Corporation has released the Novel Coronavirus Detection Kit for Wipe Tests. This reagent kit detects the novel coronavirus on surfaces quickly, easily, and with high sensitivity via the PCR test method. It is intended for use in hygiene management and health and safety... Read more

Phenomenex Introduces New bioZen Nano 75 µm LC Columns

Torrance, Calif. (February 22, 2021) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the launch of the bioZen Nano 75 µm LC Columns to the existing portfolio of  bioZen biological workflow products. The New bioZen Nano Columns offers a powerful combination two advanced particle platforms,... Read more

Pristine Sample Preparation For SEM Using Broad Ion Beam Milling

Feb. 22, 2021 Peabody, Mass. – JEOL USA introduces a new configuration of its bestselling broad ion beam milling instrument, the Cross-section Polisher (CP). The CP is widely used for preparing pristine samples prior to high resolution imaging and elemental analysis with the Scanning Electron Microscope (SEM).  The upgraded configuration includes high-speed milling, sputter coating, cryo-preparation (down... Read more

Phenomenex Introduces NEW SINGLE GC Solution for Dioxin Analysis

Torrance, Calif. (February 19, 2021) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences introduces Zebron™ ZB-Dioxin . Zebron ZB-Dioxin joins Phenomenex’s large family of GC unlimited Phase to deliver optimal performance when analyzing regulated 2,3,7,8-tetrachlorodibenzo- para-dioxin (2,3,7,8-TCDD) and 2,3,7,8 tetrachlorodibenzo- para-furan(TCDF).  EPA-1613 and EPA-8290 Dioxin methods requires... Read more

Agilent Announces Immunoassay Kit to Detect SARS-CoV-2 Antibodies

Kit marks first of multiple planned for 2021 aimed at COVID-19  SANTA CLARA, Calif., February 18, 2021  Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit intended for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma. The kit, which... Read more

Agilent Announces Higher-Sensitivity XF Analysis Solution for Low Abundant Immune Cell Metabolic Analysis

Enhanced data quality, easier workflow, and more versatile analytics using fewer cell numbers SANTA CLARA, Calif., February 17, 2021  Agilent Technologies Inc. (NYSE: A) today introduced the Agilent Seahorse XF HS Miniplate designed specifically for the Agilent Seahorse XF HS Mini Analyzer for improved immune cell metabolic analysis. Immunology and disease researchers are increasingly using rare, ex vivo, and genetically engineered... Read more